Psychedelics and schizophrenia: A mystery in history
Mark Haden, Birgitta Woods, Sarah A. Paschall
Journal of Psychedelic Studies December 2, 2023 DOI: 10.1556/2054.2023.00277 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Review Peer reviewed |
|---|---|
| Keywords | Schizophrenia object-oriented programming Population Clinical psychology |
| Citations | 3 |
| Key findings | Lower doses of psychedelics, mostly LSD, appear to have a potential beneficial impact on the negative symptoms of schizophrenia. |
Abstract
Abstract This analysis of current and historical research and clinical reports observes that the relationship between psychedelics and schizophrenia is complex and there are reports of psychedelics benefiting this population. Specifically, lower doses of psychedelics (mostly LSD) appear to have a potential beneficial impact on the negative symptoms of schizophrenia.